Too Old, Too Late, Too Risky? Plastic Surgery after Menopause

Board-certified New York City plastic surgeon Dr. Darren Smith examines what menopause actually changes about surgery and what it doesn't — including why he asks most tummy tuck patients to stop hormone therapy, while being candid that the evidence does not require him to.

What you'll hear in this episode

📊 The Age Proxy

Why a study of roughly 184,000 cosmetic procedures found no meaningful difference in complications between patients over 65 and everyone younger — and why age is standing in for the variables that actually predict outcomes.

⚠️ The Tummy Tuck Exception

The single operation where older patients did fare worse, and how a separate analysis of the same database independently identified age 55 as a risk factor within that procedure specifically.

⏳ The Estrogen Clock

Why the collagen loss that matters is measured from menopause rather than from your birthday, and how two women of the same age can arrive with entirely different tissue.

🩹 The Scar Distinction

What the healing evidence actually supports — slower scar maturation — and the claim it does not support: that the scars end up worse.

⬆️ The Upper Pole Problem

Why a standard mastopexy in this population often fails to hold upper pole fullness, why what goes up must come down, and when auto-augmentation becomes the better answer.

🔄 The Lifetime Device Question

Why choosing implants at 55 is really a decision about 65 and 75, and how that reframes the implant conversation after menopause.

💊 The Pill-Patch Divide

The one distinction that changes the hormone answer completely: why oral estrogen passes through the liver and nudges the clotting system, while transdermal estrogen appears not to — even in women with existing risk factors.

📅 The Four-Week Rule

Why stopping hormones the week before surgery is theater, how long the effect actually takes to clear, and exactly what Dr. Smith does in his own practice.

⚖️ Redistribution, Not Willpower

Why the midlife shift toward the middle is hormonal rather than a failure of discipline, and the hard limit on what liposuction can and cannot reach.

🧬 What Actually Settles

Why “wait until things settle” describes something real — the breast's fat-to-stroma balance stops shifting in the mid-fifties — and why the glandular tissue keeps changing after that.

🔍 Judgment Versus Evidence

Why you should want a surgeon who can tell you which of their rules are proven and which are judgment calls, and why uniform confidence across claims of very different quality is not expertise.

🔗 Resources and links

📍 Considering plastic surgery and wondering how menopause factors in? Schedule a consultation with Dr. Smith at the Ritz Tower, Park Avenue and East 57th Street, Manhattan.

🎧 The earlier episode referenced in this discussion: The Natural Lift: Everything You Need to Know About Auto-Augmentation Mastopexy.

🎙️ Plastics & Peptides, Dr. Smith's podcast with longevity medicine specialist Dr. Amanda Kahn — listen on Apple Podcasts or Spotify.

📚 References

Yeslev M, et al. Safety of cosmetic procedures in elderly and octogenarian patients. Aesthetic Surgery Journal. 2015;35(7):864-873. https://doi.org/10.1093/asj/sjv053

Winocour J, et al. Abdominoplasty: risk factors, complication rates, and safety of combined procedures. Plastic and Reconstructive Surgery. 2015;136(5):597e-606e. https://doi.org/10.1097/PRS.0000000000001700

Zomer HD, Cooke PS. Targeting estrogen signaling and biosynthesis for aged skin repair. Frontiers in Physiology. 2023;14:1281071. https://doi.org/10.3389/fphys.2023.1281071

Wilkinson HN, Hardman MJ. The role of estrogen in cutaneous aging and repair. Maturitas. 2017;103:60-64. https://doi.org/10.1016/j.maturitas.2017.06.026

Mittal P, et al. Venous thromboembolism (VTE) prophylaxis after abdominoplasty and liposuction: a review of the literature. Aesthetic Plastic Surgery. 2020;44(2):473-482. https://doi.org/10.1007/s00266-019-01576-2

Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https://doi.org/10.1136/bmj.k4810

Mohammed K, et al. Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism. 2015;100(11):4012-4020. https://doi.org/10.1210/jc.2015-2237

Committee on Practice Bulletins — Gynecology. Prevention of venous thromboembolism in gynecologic surgery: ACOG Practice Bulletin No. 232. Obstetrics and Gynecology. 2021;138(1):e1-e15. https://doi.org/10.1097/AOG.0000000000004445

Skeith L, Bates SM. Sex hormone influences on venous thrombotic and cardiovascular risk. New England Journal of Medicine. 2026;394(15):1514-1528. https://doi.org/10.1056/NEJMra2202438

Abouharb ALZ, et al. Withholding of hormone replacement therapy prior to total joint arthroplasty surgery to reduce the risk of postoperative thromboembolic events: is it justified? A systematic review of clinical practice guidelines. Journal of Arthroplasty. 2024;39(2):541-548.e24. https://doi.org/10.1016/j.arth.2023.08.061

Greendale GA, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865. https://doi.org/10.1172/jci.insight.124865

El Khoudary SR, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention. A scientific statement from the American Heart Association. Circulation. 2020;142(25):e506-e532. https://doi.org/10.1161/CIR.0000000000000912

Sandhu R, Chollet-Hinton L, Kirk EL, Midkiff B, Troester MA. Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma. Human Pathology. 2016;48:60-68. https://doi.org/10.1016/j.humpath.2015.09.031